Sunday, 29 March 2020

Generics News

  • Indian state to slash prices of 348 drugs

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2013

    Singapore: Tripura has become the first Indian state to announce its implementation of the country's health ministry's decision to reduce the maximum retail prices of essential drugs. The ...Read more

  • Daiichi to work with US FDA to solve Ranbaxy quality issue

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Sep, 2013

    Singapore: As a strong reaction to the import ban placed on Ranbaxy Laboratories' third manufacturing unit in India, the company's majority stakeholder, Daiichi Sankyo, has now made a state...Read more

  • Ranbaxy aiming to sell its generics in Japan

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Nov, 2013

    Singapore: Leading Indian generic drug maker, Ranbaxy Laboratories, along with its owners, Japan's second largest pharma company, Daiichi Sankyo has planned to supply medicines in Japan fro...Read more

  • Ranbaxy claims FDA form '483' not a show stopper

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 28 Jun, 2013

    Singapore: Soon after reports of Ranbaxy's Mohali manufacturing plant being issued a Form 483 by the US US FDA broke out, the company's stocks took a hammering in the market. However, the b...Read more

  • Astellas joins hands with Tecnofarma International

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jun, 2013

    Singapore: The US subsidiary of Japanese drug major Astellas Pharma has entered into a distribution agreement with Tecnofarma International to distribute enzalutamide (trade name Xtandi in ...Read more

  • Generic sodium tablets from Dr. Reddy's, Mylan hit US market

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2012

    Mumbai: Dr. Reddy's Laboratories, India's leading pharmaceutical company, recently launched Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets in the US market. They are the...Read more

  • Generics take center stage in South East Asia

    Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2013

    Singapore: The South East Asian pharmaceuticals industry is forecast to witness a boost to $3.9 billion by 2016. The industry is fast taking center stage in the region and continues to gai...Read more

  • China: GSK used sexual bribery to boost sales

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2013

    Singapore: The police in China have made it official that four senior Chinese executives of GlaxoSmithKline have been detained after investigations.  Announcing the list of proof gathered...Read more

  • Mayne Pharma acquires generic drugmaker Libertas

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2013

    Singapore: Mayne Pharma from Australia has made a second US acquisition by buying privately-held US-based generic drugmaker, Libertas Pharma. The financial terms of the acquisition are yet ...Read more

  • Bribery inquiries rising in China: SPP

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2013

    Singapore: Chinese prosecutors have received more than 600,000 inquiries about bribery records involving companies or individuals in the first six months, the Supreme People's Procuratorate...Read more

  • China bans GSK finance head from leaving country

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2013

    Singapore: Even as police in China are investigating claims of bribery against the British drug major for bribing doctors with cash and sexual favors, the head of finance of the company in ...Read more

  • UCB sues 15 firms for patent infringement

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2013

    Singapore: In a move that is threatening to become a high profile patent infringement suit, global biopharma company UCB has filed cases against 15 major pharmaceutical companies. Even big ...Read more

  • Deregulation will boost Japanese pharma sector

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Singapore: Japan's pharmaceutical industry is the second largest in the world, worth $89 billion in 2011 or 10 percent of the world market. The industry grew from $62.8 billion in 2005 to i...Read more

  • 50% of all drug firms have counter-generics team

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 26 Aug, 2013

    Singapore: A report by Cutting Edge Information titled, 'Post-patent generic and biosimilar defense: Harnessing competitive tactics to mitigate revenue erosion', has revealed that more than...Read more

  • Diabetes drug Actos banned in India

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2013

    Singapore: The Indian Health Ministry has banned the blockbuster diabetes drug Actos along with suspending sales of pain killer Analgin and anti-depressant Deanxit. The blockbuster diabete...Read more

  • Reports: GSK staff detained in 'fraud data' case in China

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jul, 2013

    Singapore: The Chinese police have reportedly detained employees of British pharmaceuticals major GlaxoSmithKline (GSK) following allegations of data fraud and bribery in the company's main...Read more

  • Dr Yusuf K Hamied: India's generics king

    Generics |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2012

    Dr Yusuf K Hamied, CMD of India's largest pharma company, Cipla, has earned many unflattering epithets for building a company that "reverse engineers life saving drugs". Big pharmas, even t...Read more

  • India to realign regulatory with pharma industry

    Generics |  Opinion | By Nandita Singh | 0 Comment | 06 Jun, 2012

    India's top drug regulatory body, the Central Drug Standard Control Organization (CDSO) is literally facing the heat, this summer. In May, the CDSO came under fire with serious allegations ...Read more



Podcast

 

Survey Box

Are women in the industry getting the required recognition for their efforts?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls